HSA
TBIO

Hussman Strategic Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Hussman Strategic Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-36,000
Closed -$594K – 401
2021
Q1 		$594K Buy
+36,000
New +$820K 0.12% 240

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hussman Strategic Advisors's TBIO Position: Q2 2021 in Review

Hussman Strategic Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 36,000 shares — an estimated $594K sold.

Hussman Strategic Advisors first reported a position in TBIO in Q1 2021 and held it in 1 quarter. The position peaked at $594K in Q1 2021. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Hussman Strategic Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Hussman Strategic Advisors sold 36,000 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $594K.
  • Hussman Strategic Advisors first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Hussman Strategic Advisors's Translate Bio, Inc. Common Stock position peaked at $594K in Q1 2021.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Hussman Strategic Advisors's 13F filing for Q2 2021, filed 3 Aug 2021.